中国冠心病患者基于有氧运动的心脏康复:一项预试验随机对照试验的研究方案
主要评价指标为试验可行性,次要指标为有氧代谢能力,探索性指标包括心血管功能相关分子生物标志物。
要点
- 在中国冠心病PCI术后患者中开展8周靶强度有氧运动心脏康复的预试验。
- 主要评价可行性,次要评价有氧代谢能力,探索性分析血液分子标志物。
- 研究结果将为未来中国冠心病心脏康复研究设计提供参考。
核心结论
- 该预试验旨在评估中国冠心病患者基于有氧运动的心脏康复的可行性,并观察有氧代谢能力与分子生物标志物变化。
研究设计与样本
- 干预组接受8周靶强度有氧运动,对照组接受8周休闲运动。
关键数值与推荐
- 主要测量指标为试验可行性;次要测量指标为有氧代谢能力;探索性测量指标为心血管功能相关的额外分子生物标志物。
临床怎么用
- 该研究尚未报告干预效果,其结果预期用于指导中国冠心病患者未来心脏康复研究的设计。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Cardiovascular disease is the leading cause of morbidity and mortality in the world, including China. Cardiac rehabilitation (CR) has been demonstrated to be beneficial in reducing cardiovascular mortality, myocardial infarction, and cerebrovascular events. This pilot study seeks to assess the feasibility of aerobic-exercise-based CR in Chinese patients with coronary heart disease (CHD) and outcomes of aerobic metabolism capacity and molecular biomarkers. METHODS/DESIGN: This study is a single-center, pilot, randomized, controlled study that is currently being carried out at a regional hospital in Shanghai. Forty patients with CHD who underwent percutaneous coronary intervention will be randomly allocated into either the intervention group or control group. Participants in the intervention group will undergo 8 weeks of aerobic exercise with targeted intensity and participants in the control group will undergo 8 weeks of leisure exercise. The primary measurement is the feasibility of the trial; the secondary measurement is the capacity of aerobic metabolism and the exploratory measurement includes additional molecular biomarkers underlying cardiovascular function. DISCUSSION: This is the first prospective randomized and controlled clinical study in China that assesses the parameters of aerobic metabolism and comprehensively screens for substantial blood biomarkers to reveal the molecular mechanisms underlying changes in cardiovascular function after aerobic exercise with targeted intensity in participants with CHD. The success of this study will contribute to guide the design of future CR studies in patients with CHD in China. TRIAL REGISTRATION: Chinese Clinical Trial Registry, ChiCTR-IPR-17010556 . Registered on 1 June 2016.
引用
- Cao RY, Zheng H, Mi Q, et al. Aerobic exercise-based cardiac rehabilitation in Chinese patients with coronary heart disease: study protocol for a pilot randomized controlled trial. Trials. 2018. PMID: 29986745. doi:10.1186/s13063-018-2771-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。